[go: up one dir, main page]

WO2004072094A3 - Hmgb1 modulator binding domain - Google Patents

Hmgb1 modulator binding domain Download PDF

Info

Publication number
WO2004072094A3
WO2004072094A3 PCT/IB2004/000986 IB2004000986W WO2004072094A3 WO 2004072094 A3 WO2004072094 A3 WO 2004072094A3 IB 2004000986 W IB2004000986 W IB 2004000986W WO 2004072094 A3 WO2004072094 A3 WO 2004072094A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding domain
hmgb1
modulator binding
modulator
hmgb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2004/000986
Other languages
French (fr)
Other versions
WO2004072094A2 (en
Inventor
Marco E Bianchi
Giovanna Alessandra Musco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fondazione Telethon
Ospedale San Raffaele SRL
Original Assignee
Fondazione Telethon
Ospedale San Raffaele SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondazione Telethon, Ospedale San Raffaele SRL filed Critical Fondazione Telethon
Priority to EP04710953A priority Critical patent/EP1592707A2/en
Publication of WO2004072094A2 publication Critical patent/WO2004072094A2/en
Publication of WO2004072094A3 publication Critical patent/WO2004072094A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hall/Mr Elements (AREA)
  • Metal-Oxide And Bipolar Metal-Oxide Semiconductor Integrated Circuits (AREA)

Abstract

An HMGB 1 modulator binding domain having the structure substantially as presented by the space filling balls in Figure 4 or Figure 11.
PCT/IB2004/000986 2003-02-14 2004-02-13 Hmgb1 modulator binding domain Ceased WO2004072094A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04710953A EP1592707A2 (en) 2003-02-14 2004-02-13 Hmgb1 modulator binding domain

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44731603P 2003-02-14 2003-02-14
US60/447,316 2003-02-14

Publications (2)

Publication Number Publication Date
WO2004072094A2 WO2004072094A2 (en) 2004-08-26
WO2004072094A3 true WO2004072094A3 (en) 2005-05-19

Family

ID=32869622

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/000986 Ceased WO2004072094A2 (en) 2003-02-14 2004-02-13 Hmgb1 modulator binding domain

Country Status (2)

Country Link
EP (1) EP1592707A2 (en)
WO (1) WO2004072094A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011235296C1 (en) 2010-03-29 2017-05-04 Nationwide Children's Hospital, Inc. Compositions and methods for the removal of biofilms
EP2613797B1 (en) 2010-09-09 2015-11-04 University Of Southern California Compositions and methods for the removal of biofilms
CN102552280A (en) * 2011-09-09 2012-07-11 中国科学院生物物理研究所 Pharmaceutical applications of glycyrrhizic acid or salt and derivative thereof
US11274144B2 (en) 2013-06-13 2022-03-15 Research Institute At Nationwide Children's Hospital Compositions and methods for the removal of biofilms
US9745366B2 (en) 2013-09-23 2017-08-29 University Of Southern California Compositions and methods for the prevention of microbial infections
US11248040B2 (en) 2013-09-26 2022-02-15 Trellis Bioscience, Llc Binding moieties for biofilm remediation
US10233234B2 (en) 2014-01-13 2019-03-19 Trellis Bioscience, Llc Binding moieties for biofilm remediation
AU2016303688B2 (en) 2015-07-31 2023-06-15 Research Institute At Nationwide Children's Hospital Peptides and antibodies for the removal of biofilms
AU2018236271B2 (en) 2017-03-15 2023-12-21 Research Institute At Nationwide Children's Hospital Composition and methods for disruption of bacterial biofilms without accompanying inflammation
CN112823038B (en) 2018-10-05 2025-10-03 国家儿童医院研究所 HMGB1 protein derivatives for biofilm removal

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HARDMAN COLIN H ET AL: "Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three- and four-dimensional NMR spectroscopy", BIOCHEMISTRY, vol. 34, no. 51, 1995, pages 16596 - 16607, XP002300628, ISSN: 0006-2960 *
OKANO MAIKO ET AL: "Biochemical characterization of cholesterol-3-sulfate as the sole effector for the phosphorylation of HMG1 by casein kinase I in vitro", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 281, no. 5, 16 March 2001 (2001-03-16), pages 1325 - 1330, XP002300630, ISSN: 0006-291X *
SAKAMOTO RYOKO ET AL: "Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro", BIOLOGICAL AND PHARMACEUTICAL BULLETIN, vol. 24, no. 8, August 2001 (2001-08-01), pages 906 - 911, XP002300629, ISSN: 0918-6158 *
THOMAS J O ET AL: "HMG1 and 2, and related 'architectural' DNA-binding proteins", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 26, no. 3, 1 March 2001 (2001-03-01), pages 167 - 174, XP004229458, ISSN: 0968-0004 *
YANG HUAN ET AL: "HMGB1 as a cytokine and therapeutic target", JOURNAL OF ENDOTOXIN RESEARCH, CHURCHILL LIVINGSTONE, EDINBURGH, GB, vol. 8, no. 6, 2002, pages 469 - 472, XP009020930, ISSN: 0968-0519 *

Also Published As

Publication number Publication date
EP1592707A2 (en) 2005-11-09
WO2004072094A2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
GB0305175D0 (en) Navigator 2.0 features
AP2005003470A0 (en) Novel peptides that bind to the erythropoietin.
WO2005047545A3 (en) Microarray controls
AP2005003420A0 (en) Acidic composition and its uses.
WO2004072094A3 (en) Hmgb1 modulator binding domain
AP2006003544A0 (en) Amino acids with affinity for the alpha2delta-protein.
Foss The hydrogen economy
PL114818U1 (en) V .03
AU2003900838A0 (en) Improvements in lock - Cont. 6
GB0323933D0 (en) The zap-o
AU2003905356A0 (en) The generator
AP2244A (en) Topical methadone compositions and methods for using the same.
HK1112001A (en) Methods and compositions for modulating vascular integrity
AU2003904072A0 (en) The Cadman Electromagnet Motor-Generator
ZA200408396B (en) Road surface composition.
AU2003283123A1 (en) The medi-cam
AU2003900333A0 (en) The crab-grab
AU2003905775A0 (en) The apprentice
GB0325792D0 (en) The super car
AU2003902116A0 (en) Improvements in Lock - Cont. 7A
PL368397A1 (en) M .511
AU2004902574A0 (en) The 'WHIRLYWEEDER'
AU2003906848A0 (en) The multi-bit
ZA200409761B (en) Enriching soils with iron.
GB0329280D0 (en) C.V.I - Central vehicle indicator

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004710953

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004710953

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004710953

Country of ref document: EP